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At present, African scientists can only participate
minimally in the genomics revolution that is
transforming the understanding, surveillance and
clinical treatment of infectious diseases. We discuss
new initiatives to equip African scientists with
knowledge of cutting-edge genomics tools, and build
a sustainable critical mass of well-trained African
infectious diseases genomics scientists.the continent, including malaria, HIV-AIDS and tubercu-
losis. If the dearth of genomics research involving AfricansBackground
The negative economic and social impact of infectious dis-
eases in Africa cannot be overemphasized; they are leading
causes of death and economic losses in the continent. One
of the major challenges in the control of infectious diseases
in Africa is inadequate knowledge and understanding of the
pathogens and their various hosts. However, as genomic
technologies have become available, and the sequencing of
both the human genome and the genomes of many patho-
gens has been completed, we are witnessing a revolution in
the way infectious disease research is approached and con-
ducted. This progress has also brought about enormous
health, scientific and economic benefits [1].
The availability of sequencing data from infectious patho-
gens represents a unique opportunity for the identification
of new drug and vaccine targets, which potentially have
value for disease management and control. These data have,
however, been predominantly benefiting researchers, ins-
titutions and laboratories in North America, Australia,
Europe and Asia, contributing to the increasing economic,
scientific and genomics knowledge gap between these geo-
graphic regions and Africa. This is partly due to the fact* Correspondence: happic@run.edu.ng
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org/publicdomain/zero/1.0/) applies to the datathat while governments in countries such as the US and
UK have increased their investment in genomics research,
there is a paucity of governmental, regional political or
economic organizational funding in Africa for genomicists
to address the burden of infectious diseases. Despite the
technological advances and significant reductions in the
cost of genomic research, African scientists are yet to use
genomics-based knowledge and tools to provide novel in-
sights into disease etiology, diagnosis, and therapy for
some of the most intractable and devastating diseases on
persists, the potential health and economic benefits eman-
ating from genomics may elude the entire continent [2].
There is therefore an important and urgent need to fa-
cilitate the establishment of a vibrant research and aca-
demic environment that is free of outside influences,
that transcends national boundaries, and that ensures
the conduct of relevant, responsive, ethical and high-
quality translational genomics-based research on infec-
tious diseases in Africa. This will depend, in part, on the
ability of African scientists to: 1) acquire the expertise and
facilities necessary to lead high-quality genomics-based re-
search aimed at understanding infectious diseases relevant
to African populations; and 2) become internationally
competitive in genomics science and its applications.New initiatives for the genomics of infectious
diseases in Africa
Some new initiatives have recently been put in place to
empower African researchers to overcome the challenges
described above and to unlock the potential for infectious
diseases control through genomics-based approaches.
These are the H3Africa consortium (www.h3africa.org),
which is funded by the National Institutes of Health (NIH)
and the Wellcome Trust, and the African Center of
Excellence for Genomics of Infectious Diseases-ACEGID
(www.acegid.org), which is funded by the World Bank.
Both initiatives are focused on capacity building, as well as
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communicable and infectious diseases, and has a major
objective to award research grants directly to African ins-
titutions in which principal investigators are based. This
allows African scientists to develop and direct their inde-
pendent research agendas. The program also encourages
the formation of intra-continental collaborations, and the
development of specific infrastructural elements, such as
African-based bio-repositories and a pan-African bioinfor-
matics network (H3ABio-Net). Furthermore, the H3Africa
initiative also includes training programs aimed at retaining
African scientists on the continent to help build a sustain-
able critical mass of genomics-based researchers [2].
The World-Bank-funded ACEGID program, which is
based at Redeemer’s University, Mowe, Nigeria, focuses
strictly on infectious diseases. ACEGID’s research-related
goals are focused on characterizing fevers of unknown
origins through microbial metagenomics. It uses field-
deployed and state-of-the-art genomics technology to
identify the pathogens driving febrile illness. ACEGID also
aims to create a foundation for African scientists to carry
out tractable and important genetic research projects en-
tirely in their own country. At present, clinical diagnostics
are unavailable for many of the pathogens that cause fe-
brile illnesses across the sub-continent. In light of this gap,
the project also seeks to employ new sequencing technolo-
gies and bioinformatics to discover novel pathogens, as
well as to develop and deploy new tools for field diagnosis
of new and known microorganisms.
By building human and infrastructural capacity for
state-of-the-art genome sequencing and field-deployable
genetics tools to inform work on microbial infection in
Africa, the ACEGID program can support the clinical
management of the most devastating diseases, and can
enable a surveillance network for some of the world’s
greatest health threats. This has been well illustrated by
the current Ebola epidemic in the West African regions.
ACEGID-established laboratories and researchers per-
formed the first diagnosis of Ebola virus disease in
Nigeria and Sierra Leone and were able to track its ori-
gin and evolution in West Africa [3].
ACEGID plans to establish lasting scientific capacity in
genomics through complementary research and education-
based goals related to the detection and control of in-
fectious diseases. The educational goals of ACEGID are to:
1) develop a critical mass of well-trained African gen-
omics scientists; 2) empower African researchers to
utilize genomics-based tools towards the control and elim-
ination of infectious diseases; 3) create genomics curricula
to support and promote cutting-edge genomics-based re-
search; and 4) engage communities in prevention efforts
and public health education.
Despite the apparent success of H3Africa and ACE-
GID, one of the major challenges to building criticalmass for genomic research in Africa will be the ability of
African institutions to retain scientific leaders who are
capable of developing and maintaining sustainable re-
search programs. This can only be achieved through the
support of national governments and of regional political
and economic organizations in providing sustained fund-
ing for all research fields, including infectious diseases
genomics and research infrastructure development. In
addition, African countries should be building their in-
frastructures to promote local innovation, and to retain
the value of their human and microbial genetic diversity.
There is also a need to develop and foster north–south,
south-south (intra- and inter-African institution) col-
laborations to develop the necessary infrastructure and
biomedical research culture required to promote genomics-
based research for infectious diseases control in Africa.
Conclusions
New initiatives to empower African scientists in genomics
have the potential not only to reduce the ‘genomics divide’
between Africa and the rest of the World, but also to
change positively the infectious diseases research and aca-
demic landscapes on the continent. The initial success of
the H3Africa and ACEGID initiatives has shown that well
thought through and articulated programs can enable
African scientists to pursue high-impact projects. This
work will not only bring regional academic and research
success for African science, but will also contribute to the
improvement of global public health.
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